Cogent Biosciences

$0.00 (0.00%) As of 12:52 PM UTC pre-market

Why Robinhood?

You can buy or sell COGT and other stocks, options, and ETFs commission-free!

About COGT

Cogent Biosciences, Inc. Common Stock, also called Cogent Biosciences, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of precision therapies for genetically defined diseases.

CEO
Andrew R. Robbins
Employees
15
Headquarters
Cambridge, Massachusetts
Founded
2014

COGT Key Statistics

Market Cap
312.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
186.16K
High Today
$8.16
Low Today
$7.90
Open Price
$7.95
Volume
184.62K
52 Week High
$14.88
52 Week Low
$1.61

COGT Earnings

-$6.06
-$4.04
-$2.02
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure